ArticleJAMA2017

FDA Approval of Nonadjunctive Use of Continuous Glucose Monitors for Insulin Dosing: A Potentially Risky Decision.

Alan R ShapiroPubMed ↗Publisher ↗

No numbers read from the abstract.